Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging.

OBJECTIVEThe objective of this study was to characterize the abnormalities revealed by diffusion tensor imaging (DTI) using MR spectroscopy (MRS) and perfusion imaging, and to evaluate the prognostic value of a proposed quantitative measure of tumor invasiveness by combining contrast-enhancing (CE) and DTI abnormalities in patients with glioblastoma.METHODSEighty-four patients with glioblastoma were recruited preoperatively. DTI was decomposed into isotropic (p) and anisotropic (q) components. The relative cerebral blood volume (rCBV) was calculated from the dynamic susceptibility contrast imaging. Values of N-acetylaspartate, myoinositol, choline (Cho), lactate (Lac), and glutamate + glutamine (Glx) were measured from multivoxel MRS and normalized as ratios to creatine (Cr). Tumor regions of interest (ROIs) were manually segmented from the CE T1-weighted (CE-ROI) and DTI-q (q-ROI) maps. Perfusion and metabolic characteristics of these ROIs were measured and compared. The relative invasiveness coefficient (RIC) was calculated as a ratio of the characteristic radii of CE-ROI and q-ROI. The prognostic significance of RIC was tested using Kaplan-Meier and multivariate Cox regression analyses.RESULTSThe Cho/Cr, Lac/Cr, and Glx/Cr in q-ROI were significantly higher than CE-ROI (p = 0.004, p = 0.005, and p = 0.007, respectively). CE-ROI had significantly higher rCBV values than q-ROI (p < 0.001). A higher RIC was associated with worse survival in a multivariate overall survival (OS) model (hazard ratio [HR] 1.40, 95% confidence interval [CI] 1.06-1.85, p = 0.016) and progression-free survival (PFS) model (HR 1.55, 95% CI 1.16-2.07, p = 0.003). An RIC cutoff value of 0.89 significantly predicted shorter OS (median 384 vs 605 days, p = 0.002) and PFS (median 244 vs 406 days, p = 0.001).CONCLUSIONSDTI-q abnormalities displayed higher tumor load and hypoxic signatures compared with CE abnormalities, whereas CE regions potentially represented the tumor proliferation edge. Integrating the extents of invasion visualized by DTI-q and CE images into clinical practice may lead to improved treatment efficacy.

[1]  K. Khalili,et al.  Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity , 2009, Cancer biology & therapy.

[2]  M. Lipton,et al.  Utility of Diffusion Tensor Imaging in Evaluation of the Peritumoral Region in Patients with Primary and Metastatic Brain Tumors , 2014, American Journal of Neuroradiology.

[3]  K. Swanson,et al.  A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle , 2007, British Journal of Cancer.

[4]  Susan M. Chang,et al.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Timothy Edward John Behrens,et al.  Characterization and propagation of uncertainty in diffusion‐weighted MR imaging , 2003, Magnetic resonance in medicine.

[6]  R. Kreis.  Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts , 2004, NMR in biomedicine.

[7]  S. Price,et al.  Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients. , 2017, Journal of neurosurgery.

[8]  E. Hoving,et al.  The role of diffusion tensor imaging in brain tumor surgery: A review of the literature , 2014, Clinical Neurology and Neurosurgery.

[9]  Kenneth Hess,et al.  The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? , 2016, Journal of neurosurgery.

[10]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[11]  Mitchel S Berger,et al.  An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.

[12]  T. Carpenter,et al.  Enhanced visualization and quantification of magnetic resonance diffusion tensor imaging using the p:q tensor decomposition. , 2006, The British journal of radiology.

[13]  Low Perfusion Compartments in Glioblastoma Quantified by Advanced Magnetic Resonance Imaging and Correlated with Patient Survival , 2017 .

[14]  J. Gillard,et al.  Imaging biomarkers of brain tumour margin and tumour invasion. , 2011, The British journal of radiology.

[15]  Walter Stummer,et al.  Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery , 2012, Journal of Neuro-Oncology.

[16]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[17]  T. Carpenter,et al.  Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. , 2006, AJNR. American journal of neuroradiology.

[18]  J. Gillard,et al.  Correlation of MR Relative Cerebral Blood Volume Measurements with Cellular Density and Proliferation in High-Grade Gliomas: An Image-Guided Biopsy Study , 2011, American Journal of Neuroradiology.

[19]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[20]  Daniel J Brat,et al.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. , 2005, Neuro-oncology.

[21]  J. Gillard,et al.  Diffusion tensor invasive phenotypes can predict progression-free survival in glioblastomas , 2013, British journal of neurosurgery.

[22]  Patrick Y Wen,et al.  Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group , 2012, Neurosurgery.

[23]  Richard S. Frackowiak,et al.  PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences , 2004, NeuroImage.

[24]  A. Padhani,et al.  Multiparametric imaging of tumor response to therapy. , 2010, Radiology.

[25]  Florian Markowetz,et al.  Intratumoral Heterogeneity of Glioblastoma Infiltration Revealed by Joint Histogram Analysis of Diffusion Tensor Imaging. , 2018, Neurosurgery.

[26]  T. Carpenter,et al.  Predicting patterns of glioma recurrence using diffusion tensor imaging , 2007, European Radiology.

[27]  Li Bai,et al.  Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer’s disease models , 2016, Scientific Reports.

[28]  Deric M. Park,et al.  Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells , 2017, Neuro-oncology.

[29]  M. McLean,et al.  Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas , 2015, Journal of magnetic resonance imaging : JMRI.